Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immatics NV (NQ: IMTX ) 11.09 +0.01 (+0.09%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Immatics NV < Previous 1 2 Next > IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q2 2024 August 13, 2024 IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace Trading SMID Biotech Stocks In A Volatile Market July 01, 2024 Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a... Via Talk Markets 12 Health Care Stocks Moving In Friday's Intraday Session May 24, 2024 Via Benzinga IMTX Stock Earnings: Immatics Beats EPS, Beats Revenue for Q4 2023 March 21, 2024 IMTX stock results show that Immatics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session March 21, 2024 Via Benzinga Why Immatics Shares Are Rising Today July 24, 2023 Immatics N.V. (NASDAQ: IMTX) shares are trading higher after the company announced Via Benzinga Recap: Immatics Q1 Earnings May 16, 2023 Via Benzinga Why Immatics Stock Is Soaring Today May 02, 2023 Investors liked what they heard in Immatics' interim results for experimental immunotherapy IMA203. Via The Motley Fool 10 Health Care Stocks Whale Activity In Today's Session March 18, 2024 Via Benzinga Top 5 Health Care Stocks That May Crash This Month June 22, 2023 The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 02, 2023 Via Benzinga What's Going On With Immatics Shares Today May 02, 2023 Immatics N.V. (NASDAQ: IMTX) shares are shooting higher today after it revealed an interim clinical data update for 11 patients with recurrent and/or refractory solid cancers treated with ACTengine... Via Benzinga US Stocks Down; Chegg Crashes After Removing Guidance On ChatGPT Concerns May 02, 2023 U.S. stocks traded lower this morning even as the Federal Reserve’s two-day meeting began. Following the market opening Tuesday, the Dow traded down 0.47% to 33,891.31 while the NASDAQ fell 0.12% to... Via Benzinga Immatics Immunotherapy Candidate Shows Confirmed Responses In Different Solid Cancers October 10, 2022 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session May 02, 2023 Via Benzinga Bristol-Myers Squibb's Breyanzi Aces Two Lymphoma Studies On Overall Response Rate Endpoint, Plus New Collaboration May 01, 2023 Bristol-Myers Squibb Co (NYSE: BMY) announced Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023 March 31, 2023 Via Benzinga First Majestic Silver, Immatics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session March 21, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session November 28, 2022 Via Benzinga Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday October 11, 2022 Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued... Via Benzinga Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session October 10, 2022 Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the... Via Benzinga Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday October 10, 2022 U.S. stocks traded lower, with the Dow Jones dropping more than 100 points on Monday. Here are some big stocks recording gained in today’s session. Via Benzinga Why Is Nutex Health (NUTX) Stock on the Move Today? October 10, 2022 Nutex Health (NUTX) stock is moving on Monday after the healthcare management company released a corporate update to investors. Via InvestorPlace Ford Stock Slumps 7% on Analyst Downgrade October 10, 2022 Ford (F) stock is losing traction on Monday after UBS analyst Patrick Hummel hit the automobile company's shares with a downgrade. Via InvestorPlace Why Is Immatics (IMTX) Stock Up 7% Today? October 10, 2022 Immatics (IMTX) stock is climbing higher on Monday after the biopharmaceutical company revealed an underwritten public offering. Via InvestorPlace Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session September 12, 2022 Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. Via Benzinga Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday September 13, 2022 Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. Via Benzinga Livent, Amgen And Some Other Big Stocks Moving Lower On Monday September 12, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary August 23, 2022 Via Benzinga Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket August 10, 2022 Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing. Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.